Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
Lukas Röthlisberger, Clinical Trainee in Surgery at Schaffhausen Hospitals, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Hämostaseologie, adding:
“I am very happy to share that our study on the real-world use of rivaroxaban in children has now been published online in Hämostaseologie.
In this retrospective study, we analyzed the use, effectiveness, and safety of rivaroxaban in 57 pediatric patients treated at the University Children’s Hospital Zurich. In our cohort, rivaroxaban was safe and effective, adding real-world evidence to the growing experience with direct oral anticoagulation in children.
I am especially grateful to Alessandra Bosch and Manuela Albisetti for their guidance, trust, and support throughout this project.
I have learned a great deal from working with them and am very thankful for the opportunity to contribute to this research.
Seeing this project progress from clinical data to presentation and now publication has been an incredibly rewarding experience.”
Title: Rivaroxaban in Paediatric Patients Beyond Clinical Trial Settings – A Real-World Retrospective Cohort Study
Authors: Lukas Röthlisberger, Alessandra Bosch, Manuela Albisetti
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery